43
Views
13
CrossRef citations to date
0
Altmetric
Review

Nucleoside transporter proteins: emerging targets for drug discovery

, , , &
Pages 515-539 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mark F. Vickers , Jing Zhang , Frank Visser, Tracey Tackaberry, Morris J. Robins, Lars P. C. Nielsen, Ireneusz Nowak, Stephen A. Baldwin, James D. Young & Carol E. Cass. (2004) Uridine Recognition Motifs of Human Equilibrative Nucleoside Transporters 1 and 2 Produced in Saccharomyces cerevisiae . Nucleosides, Nucleotides & Nucleic Acids 23:1-2, pages 361-373.
Read now
Mark F. Vickers, James D. Young, Stephen A. Baldwin, Michael J. Ellison & Carol E. Cass. (2001) Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae. Molecular Membrane Biology 18:1, pages 73-79.
Read now

Articles from other publishers (11)

Simone H. Stahl, Katherine S. Fenner, M. Raymond V. Finlay, Ravindra V. Alluri, Beth Williamson, Johan X. Johansson & Jason Kettle. 2021. The Medicinal Chemist's Guide to Solving ADMET Challenges. The Medicinal Chemist's Guide to Solving ADMET Challenges 62 108 .
Rebba C. Boswell-Casteel, Jennifer M. Johnson, Kelli D. Duggan, Zygy Roe-Žurž, Hannah Schmitz, Carter Burleson & Franklin A. Hays. (2014) FUN26 (Function Unknown Now 26) Protein from Saccharomyces cerevisiae Is a Broad Selectivity, High Affinity, Nucleoside and Nucleobase Transporter. Journal of Biological Chemistry 289:35, pages 24440-24451.
Crossref
Robert J. Paproski, Frank Visser, Jing Zhang, Tracey Tackaberry, Vijaya Damaraju, Stephen A. BaldwinJames D. Young & Carol E. Cass. (2008) Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity. Biochemical Journal 414:2, pages 291-300.
Crossref
Jing Zhang, Frank Visser, Karen M. King, Stephen A. Baldwin, James D. Young & Carol E. Cass. (2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer and Metastasis Reviews 26:1, pages 85-110.
Crossref
Jing Zhang, Kyla M. Smith, Tracey Tackaberry, Xuejun Sun, Pat Carpenter, Melissa D. Slugoski, Morris J. Robins, Lars P.C. Nielsen, Ireneusz Nowak, Stephen A. Baldwin, James D. Young & Carol E. Cass. (2006) Characterization of the Transport Mechanism and Permeant Binding Profile of the Uridine Permease Fui1p of Saccharomyces cerevisiae. Journal of Biological Chemistry 281:38, pages 28210-28221.
Crossref
Frank Visser, Stephen A. Baldwin, R. Elwyn Isaac, James D. Young & Carol E. Cass. (2005) Identification and Mutational Analysis of Amino Acid Residues Involved in Dipyridamole Interactions with Human and Caenorhabditis elegans Equilibrative Nucleoside Transporters. Journal of Biological Chemistry 280:12, pages 11025-11034.
Crossref
Vijaya L Damaraju, Sambasivarao Damaraju, James D Young, Stephen A Baldwin, John Mackey, Michael B Sawyer & Carol E Cass. (2003) Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene 22:47, pages 7524-7536.
Crossref
Miguel A Cabrita, Stephen A Baldwin, James D Young & Carol E Cass. (2002) Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes. Biochemistry and Cell Biology 80:5, pages 623-638.
Crossref
Mark F Vickers, Rakesh Kumar, Frank Visser, Jing Zhang, Jahangir Charania, R Taylor Raborn, Stephen A Baldwin, James D Young & Carol E Cass. (2002) Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae . Biochemistry and Cell Biology 80:5, pages 639-644.
Crossref
Frank Visser, Mark F. Vickers, Amy M.L. Ng, Stephen A. Baldwin, James D. Young & Carol E. Cass. (2002) Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole. Journal of Biological Chemistry 277:1, pages 395-401.
Crossref
Marilyn L. Clarke, John R. Mackey, Stephen A. Baldwin, James D. Young & Carol E. Cass. 2002. Clinically Relevant Resistance in Cancer Chemotherapy. Clinically Relevant Resistance in Cancer Chemotherapy 27 47 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.